For the better part of August, the U.S. cannabis journey remained the same: anemic volume ($15-$20M notional per session) and sentiment, for those who still cared or were still interested at all in U.S cannabis, was on life support. The week before last, not one but two U.S cannabis-focused funds unwound positions, adding additional pressure as the buyers continued to strike.
Cannabis stocks rallied for the second straight session on Thursday after a letter was reportedly leaked to Bloomberg on Wednesday that The U.S Department of Health and Human Services (HHS) recommended the Drug Enforcement Administration (DEA) reclassify cannabis from Schedule I to Schedule III under federal law. That was some leak.
Bipartisan Bill Would Eliminate Cannabis Screening for Federal Hiring, Security Clearances [FEATURE] stopthedrugwar.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stopthedrugwar.org Daily Mail and Mail on Sunday newspapers.
U.S. Lawmakers File Bill To Ease Federal Employment Restrictions On Cannabis Use hightimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hightimes.com Daily Mail and Mail on Sunday newspapers.